NYSE:VRX   VALEANT PHARMACEUTICALS INTERNATIONAL INC
134 1 1
New management has done an impressive job to turn around Valeant since Jan 2016. Under promised over delivered. Cash flow is strong and US$ index decline helps Valeant to improve its bottom line.

Technically the bottom pattern is almost finished and with a good ER in next month, I expect the rally continues.
Very interesting your point of view!
Reply
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out